CIK 0001841330 · <br>Emerging growth company
Pasithea Therapeutics Corp.
Sign in to watch- Ticker
- KTTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851591963
- Phone
- (702) 514-4174
- Business address
- 1111 LINCOLN ROAD, SUITE 500, MIAMI BEACH, FL, 33139
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 10-K Report Annual Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Delisting notice
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- DEF 14A Proxy Proxy Statement
Page 2 of 18 · 344 filings